WASHINGTON, Oct. 1 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Curia New York Inc. from its Center for Drug Evaluation and Research:

* * *

Recipient: Philip Macnabb, CEO, Curia New York, Inc., 223 South West Street, Raleigh, NC 27603, United States

(b)(4)

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER